Jelinek DF - Search Results

1

Survival of patients with clinically identified monoclonal B-cell lymphocytosis (MBL) relative to the age- and sex-matched general population.

Shanafelt TD, Kay NE, Rabe KG, Call TG, Zent CS, Schwager SM, Leis JF, Jelinek DF, Slager SL, Hanson CA. Shanafelt TD, et al. Among authors: jelinek df. Leukemia. 2012 Feb;26(2):373-6. doi: 10.1038/leu.2011.211. Epub 2011 Aug 12. Leukemia. 2012. PMID: 21836611 No abstract available.

2

MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count >or= 5 x 10(9) L(-1) but a B-cell lymphocyte count <5 x 10(9) L(-1)?

Shanafelt TD, Kay NE, Call TG, Zent CS, Jelinek DF, LaPlant B, Morice WG, Hanson CA. Shanafelt TD, et al. Among authors: jelinek df. Leuk Res. 2008 Sep;32(9):1458-61. doi: 10.1016/j.leukres.2007.11.030. Epub 2008 Jan 7. Leuk Res. 2008. PMID: 18179821 Free PMC article.

3

Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early-intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximab.

Zent CS, Secreto CR, LaPlant BR, Bone ND, Call TG, Shanafelt TD, Jelinek DF, Tschumper RC, Kay NE. Zent CS, et al. Among authors: jelinek df. Leuk Res. 2008 Dec;32(12):1849-56. doi: 10.1016/j.leukres.2008.05.014. Epub 2008 Jun 27. Leuk Res. 2008. PMID: 18584865 Free PMC article. Clinical Trial.

4

VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance.

Lee YK, Shanafelt TD, Bone ND, Strege AK, Jelinek DF, Kay NE. Lee YK, et al. Among authors: jelinek df. Leukemia. 2005 Apr;19(4):513-23. doi: 10.1038/sj.leu.2403667. Leukemia. 2005. PMID: 15703780

5

CD38 expression levels in chronic lymphocytic leukemia B cells are associated with activation marker expression and differential responses to interferon stimulation.

Pittner BT, Shanafelt TD, Kay NE, Jelinek DF. Pittner BT, et al. Among authors: jelinek df. Leukemia. 2005 Dec;19(12):2264-72. doi: 10.1038/sj.leu.2403975. Leukemia. 2005. PMID: 16208411

6

Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls.

Moreira J, Rabe KG, Cerhan JR, Kay NE, Wilson JW, Call TG, Leis JF, Jelinek DF, Schwager SM, Bowen DA, Hanson CA, Slager SL, Shanafelt TD. Moreira J, et al. Among authors: jelinek df. Leukemia. 2013 Jan;27(1):136-41. doi: 10.1038/leu.2012.187. Epub 2012 Jul 11. Leukemia. 2013. PMID: 22781591

7

Expression of TCL-1 as a potential prognostic factor for treatment outcome in B-cell chronic lymphocytic leukemia.

Browning RL, Geyer SM, Johnson AJ, Jelinek DF, Tschumper RC, Call TG, Shanafelt TD, Zent CS, Bone ND, Dewald GW, Lin TS, Heerema NA, Grever MR, Kay NE, Byrd JC, Lucas DM. Browning RL, et al. Among authors: jelinek df. Leuk Res. 2007 Dec;31(12):1737-40. doi: 10.1016/j.leukres.2007.05.020. Epub 2007 Jul 19. Leuk Res. 2007. PMID: 17659340 Free PMC article. Clinical Trial.

8

Methylprednisolone-rituximab is an effective salvage therapy for patients with relapsed chronic lymphocytic leukemia including those with unfavorable cytogenetic features.

Bowen DA, Call TG, Jenkins GD, Zent CS, Schwager SM, Van Dyke DL, Jelinek DF, Kay NE, Shanafelt TD. Bowen DA, et al. Among authors: jelinek df. Leuk Lymphoma. 2007 Dec;48(12):2412-7. doi: 10.1080/10428190701724801. Leuk Lymphoma. 2007. PMID: 18067017

9

B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome.

Shanafelt TD, Kay NE, Jenkins G, Call TG, Zent CS, Jelinek DF, Morice WG, Boysen J, Zakko L, Schwager S, Slager SL, Hanson CA. Shanafelt TD, et al. Among authors: jelinek df. Blood. 2009 Apr 30;113(18):4188-96. doi: 10.1182/blood-2008-09-176149. Epub 2008 Nov 17. Blood. 2009. PMID: 19015397 Free PMC article.

10

Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia.

Shanafelt TD, Kay NE, Rabe KG, Call TG, Zent CS, Maddocks K, Jenkins G, Jelinek DF, Morice WG, Boysen J, Schwager S, Bowen D, Slager SL, Hanson CA. Shanafelt TD, et al. Among authors: jelinek df. J Clin Oncol. 2009 Aug 20;27(24):3959-63. doi: 10.1200/JCO.2008.21.2704. Epub 2009 Jul 20. J Clin Oncol. 2009. PMID: 19620484 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

188 results

Search Page